{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:22:02Z","timestamp":1793060522849,"version":"4.5.0"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32171099"],"award-info":[{"award-number":["32171099"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31972909"],"award-info":[{"award-number":["31972909"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070502"],"award-info":[{"award-number":["82070502"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["23NSFSC1456"],"award-info":[{"award-number":["23NSFSC1456"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["2022YFS0607"],"award-info":[{"award-number":["2022YFS0607"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["2024 NSFSC0709"],"award-info":[{"award-number":["2024 NSFSC0709"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.bbrc.2025.151411","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T16:06:16Z","timestamp":1738080376000},"page":"151411","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Advancements in utilizing CD34+ stem cells for repairing diabetic vascular damage"],"prefix":"10.1016","volume":"750","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-6874-0810","authenticated-orcid":false,"given":"Yiting","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3029-8293","authenticated-orcid":false,"given":"Yan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2025.151411_bib1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/postgradmedj-2015-133281","article-title":"Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective","volume":"92","author":"Zaccardi","year":"2015","journal-title":"Postgrad med j"},{"key":"10.1016\/j.bbrc.2025.151411_bib2","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1161\/CIRCRESAHA.118.313058","article-title":"Role of resident stem cells in vessel formation and Arteriosclerosis","volume":"122","author":"Zhang","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2025.151411_bib3","author":"Madkor"},{"key":"10.1016\/j.bbrc.2025.151411_bib4","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/stmcls\/sxac035","article-title":"Impaired hematopoietic stem\/progenitor cell traffic and multi-organ damage in diabetes","volume":"40","author":"Fadini","year":"2022","journal-title":"Stem Cell."},{"key":"10.1016\/j.bbrc.2025.151411_bib5","doi-asserted-by":"crossref","first-page":"943","DOI":"10.2337\/dc12-1084","article-title":"Diabetes impairs stem cell and proangiogenic cell mobilization in humans","volume":"36","author":"Fadini","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbrc.2025.151411_bib6","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2840-10-107","article-title":"Relation between the frequency of CD34+ bone marrow derived circulating progenitor cells and the number of diseased coronary arteries in patients with myocardial ischemia and diabetes","volume":"10","author":"Bozdag-Turan","year":"2011","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.bbrc.2025.151411_bib7","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1126\/science.275.5302.964","article-title":"Isolation of putative progenitor endothelial cells for angiogenesis","volume":"275","author":"Asahara","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2025.151411_bib8","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s00125-013-3087-6","article-title":"A reappraisal of the role of circulating (progenitor) cells in the pathobiology of diabetic complications","volume":"57","author":"Fadini","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbrc.2025.151411_bib9","first-page":"361","article-title":"Endothelium grown from circulating blood on isolated intravascular dacron HUB","volume":"43","author":"Stump","year":"1963","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbrc.2025.151411_bib10","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1160\/TH04-09-0578","article-title":"Circulating endothelial cells. Biomarker of vascular disease","volume":"93","author":"Blann","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.bbrc.2025.151411_bib11","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1182\/blood.V95.3.952.003k27_952_958","article-title":"Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors","volume":"95","author":"Peichev","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2025.151411_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/cells12010112","article-title":"The long telling story of \"endothelial progenitor cells\": where are we at now?","volume":"12","author":"Vinci","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.bbrc.2025.151411_bib13","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/jcbfm.2008.92","article-title":"Circulating CD34-positive cells have prognostic value for neurologic function in patients with past cerebral infarction","volume":"29","author":"Taguchi","year":"2009","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.bbrc.2025.151411_bib14","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1161\/CIRCRESAHA.116.304187","article-title":"Circulating CD34+ progenitor cells and risk of mortality in a population with coronary artery disease","volume":"116","author":"Patel","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2025.151411_bib15","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1161\/CIRCRESAHA.116.308366","article-title":"Levels of circulating progenitor cells, cardiovascular outcomes and death: a meta-analysis of prospective observational studies","volume":"118","author":"Rigato","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2025.151411_bib16","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.atherosclerosis.2009.08.033","article-title":"Autologous stem cell therapy for peripheral arterial disease meta-analysis and systematic review of the literature","volume":"209","author":"Fadini","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbrc.2025.151411_bib17","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/sctm.20-0020","article-title":"Stem cell mobilization with plerixafor and healing of diabetic ischemic wounds: a phase IIa, randomized, double-blind, placebo-controlled trial","volume":"9","author":"Bonora","year":"2020","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.bbrc.2025.151411_bib18","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2337\/dc16-1755","article-title":"Long-term prediction of cardiovascular outcomes by circulating CD34+ and CD34+CD133+ stem cells in patients with type 2 diabetes","volume":"40","author":"Fadini","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbrc.2025.151411_bib19","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1007\/s00125-006-0401-6","article-title":"Diabetes impairs progenitor cell mobilisation after hindlimb ischaemia-reperfusion injury in rats","volume":"49","author":"Fadini","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbrc.2025.151411_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050739","article-title":"Worse clinical outcomes in acute myocardial infarction patients with type 2 diabetes mellitus: relevance to impaired endothelial progenitor cells mobilization","volume":"7","author":"Ling","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2025.151411_bib21","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002191","article-title":"Diabetes impairs hematopoietic stem cell mobilization by altering niche function","volume":"3","author":"Ferraro","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbrc.2025.151411_bib22","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jacbts.2018.10.005","article-title":"Circulating pro-vascular progenitor cell depletion during type 2 diabetes: translational insights into the prevention of ischemic complications in diabetes","volume":"4","author":"Terenzi","year":"2019","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.bbrc.2025.151411_bib23","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s40618-020-01278-6","article-title":"Effects of glucose variability on hematopoietic stem\/progenitor cells in patients with type 1 diabetes","volume":"44","author":"Boscari","year":"2021","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.bbrc.2025.151411_bib24","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00395-012-0313-1","article-title":"Stem cell compartmentalization in diabetes and high cardiovascular risk reveals the role of DPP-4 in diabetic stem cell mobilopathy","volume":"108","author":"Fadini","year":"2013","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.bbrc.2025.151411_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.1011140","article-title":"A cohort study of circulating progenitor cells after ST-segment elevation and non-ST segment elevation myocardial infarction in non-diabetic and diabetic patients","volume":"9","author":"Baumbach","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.bbrc.2025.151411_bib26","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.preteyeres.2015.08.001","article-title":"The progress in understanding and treatment of diabetic retinopathy","volume":"51","author":"Stitt","year":"2016","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.bbrc.2025.151411_bib27","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1186\/s13287-022-03073-x","article-title":"Advances in cell therapies using stem cells\/progenitors as a novel approach for neurovascular repair of the diabetic retina","volume":"13","author":"Lechner","year":"2022","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.bbrc.2025.151411_bib28","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1210\/jc.2015-1687","article-title":"Circulating progenitor cell count predicts microvascular outcomes in type 2 diabetic patients","volume":"100","author":"Rigato","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbrc.2025.151411_bib29","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1007\/s40618-023-02067-7","article-title":"Putative circulating adipose tissue-derived stem cells, obesity, and metabolic syndrome features","volume":"46","author":"Bonora","year":"2023","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.bbrc.2025.151411_bib30","doi-asserted-by":"crossref","first-page":"eadd2632","DOI":"10.1126\/sciadv.add2632","article-title":"CD34(+) cell-derived fibroblast-macrophage cross-talk drives limb ischemia recovery through the OSM-ANGPTL signaling axis","volume":"9","author":"Song","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bbrc.2025.151411_bib31","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bbrc.2022.11.080","article-title":"Single-cell analysis reveals distinct functional heterogeneity of CD34(+) cells in anagen wound and diabetic wound","volume":"639","author":"He","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2025.151411_bib32","first-page":"230","article-title":"[Analysis of the types and functions of CD34(+) cells in full-thickness skin defect wounds of normal mice and diabetic mice by single-cell RNA sequencing]","volume":"40","author":"He","year":"2024","journal-title":"Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi"},{"key":"10.1016\/j.bbrc.2025.151411_bib33","article-title":"Diabetes induces a transcriptional signature in bone marrow-derived CD34(+) hematopoietic stem cells predictive of their progeny dysfunction","volume":"22","author":"D'Alessandra","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2025.151411_bib34","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1161\/CIRCULATIONAHA.120.046038","article-title":"Bone marrow endothelial cells regulate myelopoiesis in diabetes mellitus","volume":"142","author":"Hoyer","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2025.151411_bib35","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1002\/sctm.16-0360","article-title":"Endothelial progenitors: a consensus statement on nomenclature","volume":"6","author":"Medina","year":"2017","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.bbrc.2025.151411_bib36","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1007\/s00125-008-0939-6","article-title":"Generalised reduction of putative endothelial progenitors and CXCR4-positive peripheral blood cells in type 2 diabetes","volume":"51","author":"Egan","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbrc.2025.151411_bib37","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1161\/01.ATV.0000114236.77009.06","article-title":"Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis","volume":"24","author":"Hur","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbrc.2025.151411_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106310","article-title":"Cross talk with hematopoietic cells regulates the endothelial progenitor cell differentiation of CD34 positive cells","volume":"9","author":"Kwon","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2025.151411_bib39","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1161\/CIRCRESAHA.110.231837","article-title":"Methodological development of a clonogenic assay to determine endothelial progenitor cell potential","volume":"109","author":"Masuda","year":"2011","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2025.151411_bib40","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/sctm.17-0043","article-title":"Quality-quantity control culture enhances vasculogenesis and wound healing efficacy of human diabetic peripheral blood CD34+ cells","volume":"7","author":"Tanaka","year":"2018","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.bbrc.2025.151411_bib41","doi-asserted-by":"crossref","first-page":"160","DOI":"10.5966\/sctm.2011-0023","article-title":"Development of serum-free quality and quantity control culture of colony-forming endothelial progenitor cell for vasculogenesis","volume":"1","author":"Masuda","year":"2012","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.bbrc.2025.151411_bib42","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1161\/ATVBAHA.111.226969","article-title":"Endothelial fate and angiogenic properties of human CD34+ progenitor cells in zebrafish","volume":"31","author":"Pozzoli","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbrc.2025.151411_bib43","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1160\/TH05-06-0442","article-title":"Therapeutic neovascularization by transplantation of mobilized peripheral blood mononuclear cells for limb ischemia","volume":"95","author":"Li","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.bbrc.2025.151411_bib44","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1042\/CS20201133","article-title":"ACE2 gene transfer ameliorates vasoreparative dysfunction in CD34+ cells derived from diabetic older adults","volume":"135","author":"Joshi","year":"2021","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.bbrc.2025.151411_bib45","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13287-020-01621-x","article-title":"Adipose stem cells isolated from diabetic mice improve cutaneous wound healing in streptozotocin-induced diabetic mice","volume":"11","author":"An","year":"2020","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.bbrc.2025.151411_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2019.107865","article-title":"Effects of intravitreal injection of human CD34(+) bone marrow stem cells in a murine model of diabetic retinopathy","volume":"190","author":"Yazdanyar","year":"2020","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.bbrc.2025.151411_bib47","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.21037\/atm-20-3930","article-title":"Analysis of the retinal capillary plexus layers in a murine model with diabetic retinopathy: effect of intravitreal injection of human CD34(+) bone marrow stem cells","volume":"9","author":"Cheung","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.bbrc.2025.151411_bib48","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2015.19","article-title":"Type 2 diabetes mellitus","volume":"1","author":"DeFronzo","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.bbrc.2025.151411_bib49","doi-asserted-by":"crossref","first-page":"5093","DOI":"10.1167\/iovs.10-70911","article-title":"Blockade of NADPH oxidase restores vasoreparative function in diabetic CD34+ cells","volume":"52","author":"Jarajapu","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.bbrc.2025.151411_bib50","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1186\/s12864-024-10679-3","article-title":"Transcriptomic Profile of Lin(-)Sca1(+)c-kit (LSK) cells in db\/db mice with long-standing diabetes","volume":"25","author":"Mahajan","year":"2024","journal-title":"BMC Genom."},{"key":"10.1016\/j.bbrc.2025.151411_bib51","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.cell.2017.11.034","article-title":"Modulation of myelopoiesis progenitors is an integral component of trained immunity","volume":"172","author":"Mitroulis","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2025.151411_bib52","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.3390\/ijms23042234","article-title":"Hematopoietic progenitors and the bone marrow niche shape the inflammatory response and contribute to chronic disease","volume":"23","author":"Xu","year":"2022","journal-title":"IJMS"},{"key":"10.1016\/j.bbrc.2025.151411_bib53","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-024-02195-1","article-title":"Persistent epigenetic signals propel a senescence-associated secretory phenotype and trained innate immunity in CD34+ hematopoietic stem cells from diabetic patients","volume":"23","author":"Vinci","year":"2024","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.bbrc.2025.151411_bib54","first-page":"4647","article-title":"Connection between periodontitis-induced low-grade endotoxemia and systemic diseases","volume":"22","author":"Vitkov","year":"2021","journal-title":"Neutrophils as Protagonists and Targets, IJMS"},{"key":"10.1016\/j.bbrc.2025.151411_bib55","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1161\/ATVBAHA.110.204370","article-title":"Junctional adhesion molecule A expressed on human CD34+ cells promotes adhesion on vascular wall and differentiation into endothelial progenitor cells","volume":"30","author":"Stellos","year":"2010","journal-title":"ATVB"},{"key":"10.1016\/j.bbrc.2025.151411_bib56","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.mad.2017.08.005","article-title":"The senescent bystander effect is caused by ROS-activated NF-\u03baB signalling","volume":"170","author":"Nelson","year":"2018","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.bbrc.2025.151411_bib57","doi-asserted-by":"crossref","first-page":"16489","DOI":"10.1096\/fj.202000860RR","article-title":"Incretin drugs effect on epigenetic machinery: new potential therapeutic implications in preventing vascular diabetic complications","volume":"34","author":"Scisciola","year":"2020","journal-title":"Faseb j"},{"key":"10.1016\/j.bbrc.2025.151411_bib58","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12933-022-01486-9","article-title":"Liraglutide preserves CD34(+) stem cells from dysfunction Induced by high glucose exposure","volume":"21","author":"Sforza","year":"2022","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.bbrc.2025.151411_bib59","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.2337\/db13-0894","article-title":"Diabetes causes bone marrow autonomic neuropathy and impairs stem cell mobilization via dysregulated p66Shc and Sirt1","volume":"63","author":"Albiero","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.bbrc.2025.151411_bib60","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nature17624","article-title":"Distinct bone marrow blood vessels differentially regulate haematopoiesis","volume":"532","author":"Itkin","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2025.151411_bib61","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1161\/ATVBAHA.112.300424","article-title":"Diabetes causes bone marrow endothelial barrier dysfunction by activation of the RhoA-Rho-associated kinase signaling pathway","volume":"33","author":"Mangialardi","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbrc.2025.151411_bib62","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1007\/s00395-008-0742-z","article-title":"Impaired endothelial progenitor cell function predicts age-dependent carotid intimal thickening","volume":"103","author":"Keymel","year":"2008","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.bbrc.2025.151411_bib63","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/ajh.2008.278","article-title":"Aging and hypertension are independent risk factors for reduced number of circulating endothelial progenitor cells","volume":"21","author":"Umemura","year":"2008","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.bbrc.2025.151411_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.174842","article-title":"Transforming growth factor-\u03b21\/Thrombospondin-1\/CD47 axis mediates dysfunction in CD34(+) cells derived from diabetic older adults","volume":"920","author":"Jahan","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2025.151411_bib65","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232314839","article-title":"Effects of cilostazol on angiogenesis in diabetes through adiponectin\/adiponectin receptors\/sirtuin1 signaling pathway","volume":"23","author":"Tseng","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2025.151411_bib66","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.2337\/db15-0077","article-title":"Diabetes limits stem cell mobilization following G-CSF but not plerixafor","volume":"64","author":"Fadini","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.bbrc.2025.151411_bib67","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.2337\/dc19-2227","article-title":"MicroRNA-21\/PDCD4 proapoptotic signaling from circulating CD34(+) cells to vascular endothelial cells: a potential contributor to adverse cardiovascular outcomes in patients with critical limb ischemia","volume":"43","author":"Spinetti","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbrc.2025.151411_bib68","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.2337\/db20-1045","article-title":"Inhibition of SGLT2 rescues bone marrow cell traffic for vascular repair: role of glucose control and ketogenesis","volume":"70","author":"Albiero","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/j.bbrc.2025.151411_bib69","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12010171","article-title":"Upregulation of anti-angiogenic miR-106b-3p correlates negatively with IGF-1 and vascular health parameters in a model of subclinical cardiovascular disease: study with metformin therapy","volume":"12","author":"Bakhashab","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.bbrc.2025.151411_bib70","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-016-0344-2","article-title":"Metformin improves the angiogenic potential of human CD34+ cells co-incident with downregulating CXCL10 and TIMP1 gene expression and increasing VEGFA under hyperglycemia and hypoxia within a therapeutic window for myocardial infarction","volume":"15","author":"Bakhashab","year":"2016","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.bbrc.2025.151411_bib71","doi-asserted-by":"crossref","first-page":"14537","DOI":"10.1073\/pnas.0604144103","article-title":"Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy","volume":"103","author":"Sasaki","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bbrc.2025.151411_bib72","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1002\/stem.1728","article-title":"Ex vivo molecular rejuvenation improves the therapeutic activity of senescent human cardiac stem cells in a mouse model of myocardial infarction","volume":"32","author":"Avolio","year":"2014","journal-title":"Stem Cell."},{"key":"10.1016\/j.bbrc.2025.151411_bib73","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/j.bbmt.2015.07.010","article-title":"CD34-Selected hematopoietic stem cell transplants conditioned with myeloablative regimens and antithymocyte globulin for advanced myelodysplastic syndrome: limited graft-versus-host disease without increased relapse","volume":"21","author":"Tamari","year":"2015","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.bbrc.2025.151411_bib74","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13287-015-0272-1","article-title":"Hematopoietic stem cell transplantation for multiple sclerosis: is it a clinical reality?","volume":"7","author":"Bakhuraysah","year":"2016","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.bbrc.2025.151411_bib75","doi-asserted-by":"crossref","first-page":"476","DOI":"10.2174\/1574888X12666170502095625","article-title":"Significance of CD34 negative hematopoietic stem cells and CD34 positive mesenchymal stem cells - a valuable dimension to the current understanding","volume":"12","author":"Viswanathan","year":"2017","journal-title":"Curr. Stem Cell Res. Ther."},{"key":"10.1016\/j.bbrc.2025.151411_bib76","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.2337\/diacare.28.9.2155","article-title":"Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes","volume":"28","author":"Huang","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbrc.2025.151411_bib77","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1161\/CIRCINTERVENTIONS.112.968321","article-title":"A randomized, controlled pilot study of autologous CD34+ cell therapy for critical limb ischemia","volume":"5","author":"Losordo","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.bbrc.2025.151411_bib78","doi-asserted-by":"crossref","DOI":"10.3390\/cells10051137","article-title":"Angiogenic CD34 stem cell therapy in coronary microvascular repair-A systematic review","volume":"10","author":"Rai","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.bbrc.2025.151411_bib79","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.3727\/096368916X691484","article-title":"Autologous CD34(+) cell therapy for refractory angina: 2-year outcomes from the ACT34-CMI study","volume":"25","author":"Henry","year":"2016","journal-title":"Cell Transplant."},{"key":"10.1016\/j.bbrc.2025.151411_bib80","article-title":"A systematic review of CD34+ stem cell therapy as an innovative and efficient treatment for the management of refractory angina","volume":"14","author":"Vithani","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.bbrc.2025.151411_bib81","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/SLA.0b013e3182854cf1","article-title":"Autologous bone marrow-derived cell therapy in patients with critical limb ischemia: a meta-analysis of randomized controlled clinical trials","volume":"258","author":"Teraa","year":"2013","journal-title":"Ann. Surg."},{"key":"10.1016\/j.bbrc.2025.151411_bib82","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s40259-023-00594-6","article-title":"Advanced delivery strategies for immunotherapy in type I diabetes mellitus","volume":"37","author":"Huang","year":"2023","journal-title":"BioDrugs"},{"key":"10.1016\/j.bbrc.2025.151411_bib83","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.3390\/pharmaceutics14102208","article-title":"Mesenchymal stem cell-derived extracellular vesicles: a potential therapy for diabetes mellitus and diabetic complications","volume":"14","author":"Sun","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bbrc.2025.151411_bib84","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.stemcr.2017.04.008","article-title":"MSC-Derived extracellular vesicles attenuate immune responses in two autoimmune murine models: type 1 diabetes and uveoretinitis","volume":"8","author":"Shigemoto-Kuroda","year":"2017","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.bbrc.2025.151411_bib85","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1007\/s00125-023-05934-3","article-title":"Umbilical cord-derived mesenchymal stromal cells preserve endogenous insulin production in type 1 diabetes: a Phase I\/II randomised double-blind placebo-controlled trial","volume":"66","author":"Carlsson","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbrc.2025.151411_bib86","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/stem.2445","article-title":"Concise review: perspectives and clinical implications of bone marrow and circulating stem cell defects in diabetes","volume":"35","author":"Fadini","year":"2017","journal-title":"Stem Cell."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25001251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25001251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T06:48:02Z","timestamp":1740466082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X25001251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":86,"alternative-id":["S0006291X25001251"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.151411","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advancements in utilizing CD34+ stem cells for repairing diabetic vascular damage","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.151411","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"151411"}}